1. Search results in the navigational tree (All hits)
All the results are highlighted by color in the navigational tree
(at the left-hand side) and remain so until you click on a not highlighted menu item and
thus return to the usual content navigation.
In addition, you can browse through the search results consecutively by pressing the navigational buttons
(
<
1 of
9
>).
Within the text the search result is highlighted by color.
2. Search results by relevance (Top 5)
Following is a list of the 5 most important hits ranked by relevance.
Hint: In the
Help you will find explanations about using search operators in order to conduct an extended search.
The Merck Group, which is headquartered in Darmstadt, Germany, is a global corporate group. With a history dating back nearly 350 years, it is the world’s oldest pharmaceutical and chemical company. Merck holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where Merck operates as EMD. Merck’s product portfolio ranges from innovative pharmaceuticals and biopharmaceutical products, to specialty chemicals, high-tech materials and life science tools. Merck markets its wide range of products within its four divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. Merck Group | Sales [...]
[...] 35.0 41.7 Merck Millipore 660.8 4.5 –0.1 –1.0 3.4 Merck Group 2,905.6 4.6 –0.5 5.1 9.3 All four divisions of the Merck Group posted organic sales growth in the third quarter of 2014. Achieving an absolute increase of € 63 million, which corresponded to an organic growth rate of 4.5%, Merck Serono made the largest absolute contribution to organic sales growth, followed by Merck Millipore with organic sales growth of € 29 million, equivalent to a growth rate of 4.5%, and Performance Materials with € 28 million, or 7.0%. The Consumer Health division delivered an organic sales growth rate of 1.4%, corresponding to an absolute organic sales increase of € 3 [...]
XLS Merck Serono | Key figures € million Q3 – 2014 Q3 – 20131 Change in % Jan.–Sept. 2014 Jan.–Sept. 20131 Change in % 1 The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 1,490.8 1,497.9 –0.5 4,422.6 4,540.5 –2.6 Sales 1,464.6 1,412.8 3.7 4,285.9 4,269.1 0.4 Operating result (EBIT) 236.9 240.5 –1.5 712.4 677.1 5.2 Margin (% of sales) 16.2 17.0 16.6 15.9 EBITDA 436.2 445.8 –2.2 1,308.4 1,331.8 –1.8 Margin (% of sales) 29.8 31.6 30.5 31.2 EBITDA pre one-time items 448.7 467.4 –4.0 1,338.7 1,379.9 –3.0 Margin (% of sales) 30.6 33.1 31.2 32.3 Business free cash flow 377.3 512.0 –26.3 [...]
XLS Consumer Health | Key figures € million Q3 – 2014 Q3 – 20131 Change in % Jan.–Sept. 2014 Jan.–Sept. 20131 Change in % 1 The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 205.0 201.7 1.6 570.6 563.6 1.2 Sales 204.1 201.2 1.5 569.1 561.8 1.3 Operating result (EBIT) 42.1 55.1 –23.7 115.7 126.1 –8.2 Margin (% of sales) 20.6 27.4 20.3 22.4 EBITDA 44.6 57.1 –21.9 123.0 133.0 –7.5 Margin (% of sales) 21.8 28.4 21.6 23.7 EBITDA pre one-time items 48.6 58.2 –16.5 131.2 132.9 –1.3 Margin (% of sales) 23.8 28.9 23.1 23.7 Business free cash flow 13.2 36.9 –64.1 65.6 108.7 –39.6 [...]
[...] organization and reporting structure of the Merck Group. The fields of activity of the individual divisions are described in detail in the sections about the divisions in the interim management report. The column “Corporate and Other” includes assets and liabilities as well as income and expenses that cannot be directly allocated to the reportable segments. These mainly relate to Group functions. Moreover, the column serves the reconciliation to the Group numbers. The cash flows from the financial result and income taxes are also disclosed under “Corporate and Other”. Apart from sales, the success of a segment is mainly determined by EBITDA pre one-time [...]
